What is the management of rhabdomyolysis (rhabdo)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The management of rhabdomyolysis should prioritize aggressive intravenous fluid resuscitation with isotonic fluids, such as normal saline, at initial rates of 1-2 L/hour, adjusted based on clinical response, to maintain urine output at 200-300 mL/hour. This approach is crucial in preventing acute kidney injury by flushing myoglobin from the kidneys and reducing the risk of tubular obstruction 1. The goal of fluid resuscitation is to maintain adequate urine output, which helps in removing myoglobin and other toxic substances from the body.

Key Components of Management

  • Aggressive fluid resuscitation with isotonic fluids
  • Monitoring of creatine kinase (CK) levels, electrolytes, renal function, and urine output
  • Prompt correction of electrolyte abnormalities, particularly hyperkalemia
  • Consideration of urinary alkalinization with sodium bicarbonate in severe cases
  • Renal replacement therapy (dialysis) for patients with refractory hyperkalemia, severe acidosis, or volume overload

Importance of Early Intervention

Early recognition and management of rhabdomyolysis are critical in reducing morbidity and mortality. Raising CPK levels above five times normal (approximately 1000 IU/L) is a sign of rhabdomyolysis, and levels above 75,000 IU/L are associated with a high incidence of acute kidney injury 1. Therefore, prompt initiation of aggressive fluid resuscitation and monitoring of CK levels and renal function are essential in the management of rhabdomyolysis.

Addressing Underlying Causes

Identifying and addressing the underlying cause of rhabdomyolysis, whether it's medication-related, trauma, excessive exercise, or other factors, is also crucial in the management of the condition. Patients should avoid nephrotoxic medications, and fluid therapy should be continued until CK levels decrease substantially, typically to below 1,000 U/L 1.

From the Research

Management of Rhabdomyolysis

The management of rhabdomyolysis involves several key components, including:

  • Aggressive intravenous saline resuscitation to maintain a urine output of at least 300 mL/hour 2
  • Management of significant electrolyte abnormalities to avoid cardiac arrhythmias and arrest 2
  • Use of sodium bicarbonate for patients who are acidotic, and mannitol for those whose urine output is not at goal 2
  • Decompressive fasciotomy for definitive management of compartment syndrome 2
  • Treatment of the underlying cause of the muscle insult 3
  • Early and aggressive fluid replacement using crystalloid solution to prevent and treat acute kidney injury (AKI) 3
  • Electrolyte imbalances must be treated with standard medical management 3

Prevention of Acute Kidney Injury

Prevention of acute kidney injury (AKI) is a crucial aspect of rhabdomyolysis management, with studies suggesting that:

  • Volume repletion, treatment with mannitol, and urinary alkalinization as soon as possible after muscle injury can minimize the risk of AKI 4
  • Prophylactic treatment with saline, mannitol, and sodium bicarbonate can totally avoid progression to established renal failure 4
  • However, once appropriate saline expansion is provided, the association of mannitol and bicarbonate seems to be unnecessary 4

Clinical Outcomes

Clinical outcomes for patients with rhabdomyolysis can vary, with:

  • Overall mortality ranging from 16% 5
  • Acute kidney injury occurring in up to 43% of patients 5
  • Severe acute kidney injury (stage 3) having a mortality of 50% 5
  • Length of stay being significantly prolonged in the presence of acute kidney injury 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rhabdomyolysis.

Disease-a-month : DM, 2020

Research

Spectrum of rhabdomyolysis in an acute hospital.

Irish journal of medical science, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.